HOTH

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Hoth Therapeutics Inc

NASDAQ | HOTH

1.37

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 24, 2025)

$18.03M

Market Cap

-

P/E Ratio

-1.04

EPS

$2.79

52 Week High

$0.65

52 Week Low

HEALTHCARE

Sector

HOTH Chart

Recent Chart
Price Action

HOTH Technicals

Tags:

HOTH Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$8.2M
Selling General And Administrative $5M
Research And Development $3.2M
Operating Expenses $8.2M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.2M
Income Before Tax -$8.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$8.2M
Comprehensive Income Net Of Tax -
Ebit -$16M
Ebitda -$8.2M
Net Income -$8.2M

Revenue & Profitability

Earnings Performance

HOTH Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $7.7M
Total Current Assets $7.6M
Cash And Cash Equivalents At Carrying Value $7M
Cash And Short Term Investments $7M
Inventory -
Current Net Receivables $47K
Total Non Current Assets $68K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $37K
Short Term Investments -
Other Current Assets $559K
Other Non Current Assets -
Total Liabilities $834K
Total Current Liabilities $831K
Current Accounts Payable $412K
Deferred Revenue -
Current Debt -
Short Term Debt $57K
Total Non Current Liabilities $2.7K
Capital Lease Obligations $31K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $31K
Other Current Liabilities $362K
Other Non Current Liabilities -
Total Shareholder Equity $6.9M
Treasury Stock -
Retained Earnings -$60M
Common Stock $804
Common Stock Shares Outstanding $6.4M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$7M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $4.7M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$8.2M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$8.2M
Selling General And Administrative $5M
Research And Development $3.2M
Operating Expenses $8.2M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.2M
Income Before Tax -$8.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$8.2M
Comprehensive Income Net Of Tax -
Ebit -$16M
Ebitda -$8.2M
Net Income -$8.2M

HOTH News

HOTH Profile

Hoth Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Hoth Therapeutics Inc. is a biopharmaceutical company based in New York that specializes in developing innovative therapies for dermatological conditions. With a pipeline that targets unmet medical needs, Hoth aims to provide advanced treatment options for patients suffering from skin diseases. The company's commitment to research and development, combined with a strategic approach to partnerships and collaborations, positions it to make significant contributions to the dermatology sector. As it navigates the complexities of clinical trials and regulatory approval, Hoth Therapeutics is poised for potential growth in a market with increasing demand for effective dermatological treatments.

BYND
-23.06%
$2.18
SCNX
+354.94%
$2.60
WGRX
+185.43%
$1.14
TOVX
+1.63%
$0.34
YYAI
-14.98%
$0.07
VIVK
+11.91%
$0.29
F
+12.15%
$13.84
INTC
+0.31%
$38.28
YDKG
-15.04%
$0.06
BURU
+15.68%
$0.39
CGBS
-39.47%
$0.03
DVLT
+52.00%
$3.42
CENN
-0.74%
$0.21
VHAI
0.00%
$0.00
ASST
+27.28%
$1.10
NVDA
+2.25%
$186.26
NOK
+11.17%
$6.17
BITF
+10.68%
$4.61
TSLA
-3.39%
$433.72
AAL
+7.90%
$13.78
DNN
+2.93%
$2.81
RGTI
-1.90%
$38.84
CJET
+27.98%
$0.11
T
+2.11%
$25.14
PLUG
+2.43%
$2.95
ADTX
-28.06%
$0.21
RIG
+0.25%
$3.90
AMD
+7.63%
$252.92
AXDX
-61.36%
$0.03
ABEV
-0.90%
$2.19
QBTS
+5.15%
$32.65
RF
+1.95%
$24.57
SMCI
-8.72%
$47.92
LAES
+22.55%
$7.01
SOFI
+3.31%
$29.01
GRAB
+1.77%
$5.72
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
NUAI
+48.35%
$5.86
WTO
-7.14%
$0.06
TLRY
+0.67%
$1.49
QS
+14.73%
$16.82
SNAP
+1.01%
$7.95
CIFR
+19.73%
$20.66
CAN
+7.38%
$1.89
JOBY
+1.29%
$15.67
ADAP
-7.57%
$0.06
AIRE
-22.42%
$0.76
ETHD
-3.40%
$3.83
ACHR
+3.52%
$11.29
IONZ
-4.02%
$3.82
RMBL
+60.50%
$3.21
AMZN
+1.41%
$224.21
RXRX
+5.41%
$6.04
BAC
+1.56%
$52.57
NIO
+0.21%
$6.90
ADD
-25.47%
$0.05
AAPL
+1.24%
$262.82
VLY
+4.24%
$10.56
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
GPUS
-0.28%
$0.38
RR
+12.17%
$6.08
AMC
-1.46%
$2.69
SRM
+53.27%
$10.30
PLTR
+2.29%
$184.63
NVTS
+3.37%
$14.07
BTBT
+4.97%
$3.90
CLOV
+19.37%
$3.82
UUUU
+0.47%
$21.36
BTG
-0.47%
$5.20
DFLI
+13.27%
$1.28
RVPH
+18.99%
$0.67
BBD
+0.14%
$3.35
HPE
+0.43%
$23.19
MARA
+1.66%
$19.54
CUTR
-10.19%
$0.09
APLD
+0.14%
$33.43
PBR
-0.84%
$11.74
NAKA
+5.66%
$0.84
WU
+10.19%
$8.97
WLGS
-5.57%
$0.04
GOOGL
+2.70%
$259.92
RIVN
-0.84%
$12.98
SOUN
-1.42%
$17.98
SCWO
+32.07%
$0.48
PFE
+0.36%
$24.76
IONQ
+1.56%
$60.30
WULF
+6.44%
$13.71
VZ
+1.09%
$38.82
ETWO
0.00%
$3.30
LAZR
+31.36%
$2.22
RGTZ
+3.08%
$15.36
MU
+5.95%
$219.02
JBLU
0.00%
$4.57
CLSK
+9.59%
$19.36
WBD
-0.47%
$21.15
LUMN
+3.78%
$8.08
HOOD
+4.06%
$139.79
SMR
+0.37%
$37.70
BYND
-23.06%
$2.18
SCNX
+354.94%
$2.60
WGRX
+185.43%
$1.14
TOVX
+1.63%
$0.34
YYAI
-14.98%
$0.07
VIVK
+11.91%
$0.29
F
+12.15%
$13.84
INTC
+0.31%
$38.28
YDKG
-15.04%
$0.06
BURU
+15.68%
$0.39
CGBS
-39.47%
$0.03
DVLT
+52.00%
$3.42
CENN
-0.74%
$0.21
VHAI
0.00%
$0.00
ASST
+27.28%
$1.10
NVDA
+2.25%
$186.26
NOK
+11.17%
$6.17
BITF
+10.68%
$4.61
TSLA
-3.39%
$433.72
AAL
+7.90%
$13.78
DNN
+2.93%
$2.81
RGTI
-1.90%
$38.84
CJET
+27.98%
$0.11
T
+2.11%
$25.14
PLUG
+2.43%
$2.95
ADTX
-28.06%
$0.21
RIG
+0.25%
$3.90
AMD
+7.63%
$252.92
AXDX
-61.36%
$0.03
ABEV
-0.90%
$2.19
QBTS
+5.15%
$32.65
RF
+1.95%
$24.57
SMCI
-8.72%
$47.92
LAES
+22.55%
$7.01
SOFI
+3.31%
$29.01
GRAB
+1.77%
$5.72
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
NUAI
+48.35%
$5.86
WTO
-7.14%
$0.06
TLRY
+0.67%
$1.49
QS
+14.73%
$16.82
SNAP
+1.01%
$7.95
CIFR
+19.73%
$20.66
CAN
+7.38%
$1.89
JOBY
+1.29%
$15.67
ADAP
-7.57%
$0.06
AIRE
-22.42%
$0.76
ETHD
-3.40%
$3.83
ACHR
+3.52%
$11.29
IONZ
-4.02%
$3.82
RMBL
+60.50%
$3.21
AMZN
+1.41%
$224.21
RXRX
+5.41%
$6.04
BAC
+1.56%
$52.57
NIO
+0.21%
$6.90
ADD
-25.47%
$0.05
AAPL
+1.24%
$262.82
VLY
+4.24%
$10.56
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
GPUS
-0.28%
$0.38
RR
+12.17%
$6.08
AMC
-1.46%
$2.69
SRM
+53.27%
$10.30
PLTR
+2.29%
$184.63
NVTS
+3.37%
$14.07
BTBT
+4.97%
$3.90
CLOV
+19.37%
$3.82
UUUU
+0.47%
$21.36
BTG
-0.47%
$5.20
DFLI
+13.27%
$1.28
RVPH
+18.99%
$0.67
BBD
+0.14%
$3.35
HPE
+0.43%
$23.19
MARA
+1.66%
$19.54
CUTR
-10.19%
$0.09
APLD
+0.14%
$33.43
PBR
-0.84%
$11.74
NAKA
+5.66%
$0.84
WU
+10.19%
$8.97
WLGS
-5.57%
$0.04
GOOGL
+2.70%
$259.92
RIVN
-0.84%
$12.98
SOUN
-1.42%
$17.98
SCWO
+32.07%
$0.48
PFE
+0.36%
$24.76
IONQ
+1.56%
$60.30
WULF
+6.44%
$13.71
VZ
+1.09%
$38.82
ETWO
0.00%
$3.30
LAZR
+31.36%
$2.22
RGTZ
+3.08%
$15.36
MU
+5.95%
$219.02
JBLU
0.00%
$4.57
CLSK
+9.59%
$19.36
WBD
-0.47%
$21.15
LUMN
+3.78%
$8.08
HOOD
+4.06%
$139.79
SMR
+0.37%
$37.70
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.